Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.

Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.
复制标题

抑制白介素1受体/TOLL样受体信号传导通过剪接的短形式的MyD88抑制是由于其未能募集IRAK-4所致。

DOI:
10.1084/jem.20021790
复制
发表时间:
2003-01-20
影响因子:
15.3
通讯作者:
Tschopp, J
Tschopp, J
中科院分区:
医学1区
文献类型:
--
作者:
Burns, K;Janssens, S;Brissoni, B;Olivos, N;Beyaert, R;Tschopp, J

文献摘要

参考文献

被引文献

相似文献

toll样受体(TLRs)和促炎白细胞介素1受体(IL-1R)家族成员依赖于MyD88的存在来进行有效的信号转导。MyD88 (n端死亡结构域[DD]和cooh端Toll/IL-1受体[TIR]结构域)的双体性质允许它将IL-1R/TLR的TIR结构域与称为IL-1R相关激酶(IRAK)-1的丝氨酸/苏氨酸激酶的DD连接起来。这触发IRAK-1磷酸化,进而激活多种信号级联反应,如转录因子核因子-κB的激活。相反,MyD88短链(MyD88s)的表达会导致IL-1/脂多糖诱导的NF-κB活化的关闭。MyD88s是MyD88的一种选择性剪接形式,只缺乏分隔DD和TIR结构域的短中间结构域。在这里,我们为这种差异提供分子解释。MyD88与IRAK-4有强烈的相互作用,IRAK-4是一种新发现的IL-1R/TLR信号通路必需的激酶。在MyD88s存在下,IRAK-1不会磷酸化,也不会激活NF-κB,也不会泛素化。因此,myd88作为IL-1R/TLR/ myd88触发信号的负调控因子,导致先天免疫应答的转录控制负调控。
Toll-like receptors (TLRs) and members of the proinflammatory interleukin 1 receptor (IL-1R) family are dependent on the presence of MyD88 for efficient signal transduction. The bipartite nature of MyD88 (N-terminal death domain [DD] and COOH-terminal Toll/IL-1 receptor [TIR] domain) allows it to link the TIR domain of IL-1R/TLR with the DD of the Ser/Thr kinase termed IL-1R–associated kinase (IRAK)-1. This triggers IRAK-1 phosphorylation and in turn the activation of multiple signaling cascades such as activation of the transcription factor nuclear factor (NF)-κB. In contrast, expression of MyD88 short (MyD88s), an alternatively spliced form of MyD88 that lacks only the short intermediate domain separating the DD and TIR domains, leads to a shutdown of IL-1/lipopolysaccharide-induced NF-κB activation. Here, we provide the molecular explanation for this difference. MyD88 but not MyD88s strongly interacts with IRAK-4, a newly identified kinase essential for IL-1R/TLR signaling. In the presence of MyD88s, IRAK-1 is not phosphorylated and neither activates NF-κB nor is ubiquitinated. Thus, MyD88s acts as a negative regulator of IL-1R/TLR/MyD88-triggered signals, leading to a transcriptionally controlled negative regulation of innate immune responses.
DOI: 10.1016/s1074-7613(00)80086-2
发表时间: 1999-07-01
期刊: IMMUNITY
影响因子: 32.4
作者:
Kawai, T;Adachi, O;Akira, S
通讯作者: Akira, S
DOI: 10.1126/science.271.5252.1128
发表时间: 1996-02-23
期刊: SCIENCE
影响因子: 56.9
作者:
Cao, ZD;Henzel, WJ;Gao, XO
通讯作者: Gao, XO
DOI: 10.1038/nature736
发表时间: 2002-04-18
期刊: NATURE
影响因子: 64.8
作者:
Suzuki, N;Suzuki, S;Yeh, WC
通讯作者: Yeh, WC
DOI: 10.1016/0014-5793(96)00283-9
发表时间: 1996-04-08
期刊: FEBS LETTERS
影响因子: 3.5
作者:
DeValck, D;Heyninck, K;Fiers, W
通讯作者: Fiers, W
DOI: 10.1084/jem.187.12.2073
发表时间: 1998-06-15
影响因子: 15.3
作者:
Kanakaraj, P;Schafer, PH;Fung-Leung, WP
通讯作者: Fung-Leung, WP